Table 3.
Variable | Comparison | HR (95% CI) | P value |
NMIBC group | With prior prostate cancer RT vs without prior RT | 0.99 (0.61-1.58) | .95 |
Age at Bladder Cancer Diagnosis | 1-unit Increase (per 10 years) | 1.03 (0.89, 1.19) | .68 |
White | No vs Yes | 1.03 (0.66, 1.60) | .90 |
Rural-Urban SEER Status | Nonmetropolitan vs Metropolitan Counties | 1.33 (1.06, 1.67) | 0.01 |
Categorical Charlson Comorbidity Index score | 2-3 vs 0-1 | 0.92 (0.72-1.16) | .47 |
≥4 vs 0-1 | 1.00 (0.68-1.46) | >0.99 | |
No. of TURBT after bladder cancer diagnosis | 1-unit Increase | 1.14 (1.11-1.17) | <.001 |
AJCC T stage | T1 vs Ta | 3.36 (2.65-4.26) | <.001 |
Tis vs Ta | 2.14 (1.51-3.03) | <.001 |
Abbreviations: AJCC, American Joint Committee on Cancer; HR, hazard ratio; NMIBC, non–muscle-invasive bladder cancer; RT, radiation therapy; TURBT, transurethral resections of bladder tumor.